Drug Search Results

Tacrine

Alternative Names: tacrine, c-110, cognex
Latest Update: 2024-12-13
Latest Update Note: News Article

Product Description

Mechanisms of Action: ACHE Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Injection

FDA Designation: None *

Approval Status: Approved

Approved Indications: None

Known Adverse Events: None

Company: Ocugenix Corporation
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tacrine

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Neovascular age-related macular degeneration|Wet Macular Degeneration

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
OCU-10-C-110-CS101	P1	Recruiting	Wet Macular Degeneration\|Neovascular age-related macular degeneration	2025-05-01

Recent News Events

Date	Type	Title
12/13/2024	News Article	Machine Vision (MV) Camera Market , 47% of Growth to Originate from APAC, Technavio
12/10/2024	News Article	Laser Photonics Advances PCB Marking Technology R&D for Electronics and Semiconductor Manufacturing
11/22/2024	News Article	Machine Vision Camera Market to Grow by USD 1.74 Billion (2024-2028), Driven by Rising Demand in Non-Industrial Sectors, AI Redefining Market Landscape - Technavio
10/30/2024	News Article	Cognex Declares Quarterly Cash Dividend

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions